JPH0535137B2 - - Google Patents
Info
- Publication number
- JPH0535137B2 JPH0535137B2 JP61132777A JP13277786A JPH0535137B2 JP H0535137 B2 JPH0535137 B2 JP H0535137B2 JP 61132777 A JP61132777 A JP 61132777A JP 13277786 A JP13277786 A JP 13277786A JP H0535137 B2 JPH0535137 B2 JP H0535137B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- cyclopentenone
- optically active
- cyclopentanedione
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- DHNDDRBMUVFQIZ-UHFFFAOYSA-N 4-hydroxycyclopent-2-en-1-one Chemical compound OC1CC(=O)C=C1 DHNDDRBMUVFQIZ-UHFFFAOYSA-N 0.000 claims description 22
- 230000003287 optical effect Effects 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 19
- LOGSONSNCYTHPS-UHFFFAOYSA-N cyclopentane-1,3-dione Chemical compound O=C1CCC(=O)C1 LOGSONSNCYTHPS-UHFFFAOYSA-N 0.000 claims description 15
- -1 tetrafluoroborate Chemical group 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000010948 rhodium Substances 0.000 claims description 11
- 229910052703 rhodium Inorganic materials 0.000 claims description 8
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 8
- 239000003446 ligand Substances 0.000 claims description 4
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 claims description 3
- WOPKYMRPOKFYNI-UHFFFAOYSA-N 2-hydroxycyclopent-2-en-1-one Chemical compound OC1=CCCC1=O WOPKYMRPOKFYNI-UHFFFAOYSA-N 0.000 claims description 3
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical group OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 2
- CIISBNCSMVCNIP-UHFFFAOYSA-N cyclopentane-1,2-dione Chemical compound O=C1CCCC1=O CIISBNCSMVCNIP-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DHNDDRBMUVFQIZ-SCSAIBSYSA-N (4s)-4-hydroxycyclopent-2-en-1-one Chemical compound O[C@H]1CC(=O)C=C1 DHNDDRBMUVFQIZ-SCSAIBSYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- WYURNTSHIVDZCO-SVYQBANQSA-N oxolane-d8 Chemical compound [2H]C1([2H])OC([2H])([2H])C([2H])([2H])C1([2H])[2H] WYURNTSHIVDZCO-SVYQBANQSA-N 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DHNDDRBMUVFQIZ-BYPYZUCNSA-N (4r)-4-hydroxycyclopent-2-en-1-one Chemical compound O[C@@H]1CC(=O)C=C1 DHNDDRBMUVFQIZ-BYPYZUCNSA-N 0.000 description 1
- VZFDTHXGWAPDKE-UHFFFAOYSA-N (5-oxocyclopenten-1-yl) acetate Chemical compound CC(=O)OC1=CCCC1=O VZFDTHXGWAPDKE-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- LINPIYWFGCPVIE-UHFFFAOYSA-N 2,4,6-trichlorophenol Chemical compound OC1=C(Cl)C=C(Cl)C=C1Cl LINPIYWFGCPVIE-UHFFFAOYSA-N 0.000 description 1
- JLHHEZMOIADYNC-UHFFFAOYSA-N 2-dimethylsilyloxycyclopent-2-en-1-one Chemical compound C[SiH](OC=1C(CCC=1)=O)C JLHHEZMOIADYNC-UHFFFAOYSA-N 0.000 description 1
- FSGHEPDRMHVUCQ-UHFFFAOYSA-N 2-ethoxyprop-1-ene Chemical compound CCOC(C)=C FSGHEPDRMHVUCQ-UHFFFAOYSA-N 0.000 description 1
- HDHBKTWWMRSPNH-UHFFFAOYSA-N 3,5,5-trichloro-1,4-dihydroxycyclopent-2-ene-1-carboxylic acid Chemical compound OC1C(Cl)=CC(O)(C(O)=O)C1(Cl)Cl HDHBKTWWMRSPNH-UHFFFAOYSA-N 0.000 description 1
- UWDMKTDPDJCJOP-UHFFFAOYSA-N 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-ium-4-carboxylate Chemical compound CC1(C)CC(O)(C(O)=O)CC(C)(C)N1 UWDMKTDPDJCJOP-UHFFFAOYSA-N 0.000 description 1
- GOYQSRNEVPZKQV-UHFFFAOYSA-N 6-ethoxy-4,6-dioxohexanoic acid Chemical compound CCOC(=O)CC(=O)CCC(O)=O GOYQSRNEVPZKQV-UHFFFAOYSA-N 0.000 description 1
- FDSYWIWRUBJSDE-UHFFFAOYSA-N 6-oxabicyclo[3.1.0]hexan-2-one Chemical compound O=C1CCC2OC12 FDSYWIWRUBJSDE-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GMEONFUTDYJSNV-UHFFFAOYSA-N Ethyl levulinate Chemical compound CCOC(=O)CCC(C)=O GMEONFUTDYJSNV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930126263 Maytansine Natural products 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- YNCKAQVPQJWLJW-ZETCQYMHSA-N [(1r)-4-oxocyclopent-2-en-1-yl] acetate Chemical compound CC(=O)O[C@@H]1CC(=O)C=C1 YNCKAQVPQJWLJW-ZETCQYMHSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- KBWQANJOWOGOHL-UHFFFAOYSA-N cyclopent-2-ene-1,1-diol Chemical compound OC1(O)CCC=C1 KBWQANJOWOGOHL-UHFFFAOYSA-N 0.000 description 1
- WEIMJSIRDZDHAH-UHFFFAOYSA-N cyclopent-3-en-1-ol Chemical compound OC1CC=CC1 WEIMJSIRDZDHAH-UHFFFAOYSA-N 0.000 description 1
- MCFZBCCYOPSZLG-UHFFFAOYSA-N cyclopent-4-ene-1,3-dione Chemical compound O=C1CC(=O)C=C1 MCFZBCCYOPSZLG-UHFFFAOYSA-N 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000011982 enantioselective catalyst Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- WKPWGQKGSOKKOO-RSFHAFMBSA-N maytansine Chemical compound CO[C@@H]([C@@]1(O)C[C@](OC(=O)N1)([C@H]([C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(C)=O)CC(=O)N1C)C)[H])\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 WKPWGQKGSOKKOO-RSFHAFMBSA-N 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ïŒç£æ¥äžã®å©çšåéïŒ
æ¬çºæã¯ãå
åŠæŽ»æ§ïŒâããããã·âïŒâã·ã¯
ããã³ããã³ããã³é¢é£ååç©ã®è£œæ³ã«é¢ããã
æŽã«è©³çŽ°ã«ã¯æ¬çºæã¯ãïŒâããããã·âïŒâã·
ã¯ããã³ããã³ãå
åŠæŽ»æ§ããžãŠã é¯äœãšæ¥è§Šã
ããããšã«ããäžæ¹ã®å
åŠç°æ§äœãéžæçã«ç°æ§
åããããïŒïŒïŒâã·ã¯ããã³ã¿ã³ãžãªã³ãšãã
åæã«ïŒ²ãŸãã¯ïŒ³é
äœã®å
åŠæŽ»æ§ãèªèµ·ãããïŒ
âããããã·âïŒâã·ã¯ããã³ããã³ã®æ°èŠãªè£œ
æ³ã«é¢ããã
ããã補é æ³ã«ããã°ãçš®ã
ã®è¬çäœçšãæã
ãããã¹ã¿ã°ã©ã³ãžã³ãããã¯å¶ã¬ã³äœçšãæã
ãã¡ã€ã¿ã³ã·ã³çã®çš®ã
ã®å»è¬åã®è£œé äžéäœãš
ãªãå
åŠæŽ»æ§ãªïŒâããããã·âïŒâã·ã¯ããã³
ããã³é¡ãé«åçã§å¹çããåŸãããšãã§ããæŽ
ã«ããã補é æ³ã¯ç«äœååŠäžæ¥µããŠæ矩ãã補é
æ³ã§ããã
ïŒåŸæ¥æè¡ïŒ
åŸæ¥ã(R)âïŒâããããã·âïŒâã·ã¯ããã³ã
ãã³ã(S)âïŒâããããã·âïŒâã·ã¯ããã³ãã
ã³çã®å
åŠæŽ»æ§ãªïŒâããããã·âïŒâã·ã¯ãã
ã³ããã³é¡ã®è£œé æ³ãšããŠã¯ãäŸãã°æ¬¡ã®ãããª
補é æ³ãç¥ãããŠããã
ããªãã¡ã
(1) ã·ã¯ããã³ã¿ãžãšã³ããåŸããããžã¢ã»ãã
ã·ã·ã¯ããã³ãâïŒâãšã³ãé
µçŽ ã«ããå æ°Žå
解ããŠãïŒ(R)âã¢ã»ããã·âïŒ(R)âããããã·
ã·ã¯ããã³ãâïŒâãšã³ãåŸã次ãã§ãããäº
é
žåãã³ã¬ã³ã§é
žåããŠãïŒ(R)âã¢ã»ããã·ã·
ã¯ããã³ãâïŒâãšã³âïŒâãªã³ãåŸãããã
å¿
èŠã«å¿ããŠå æ°Žå解é
µçŽ ã§è±ä¿è·ããŠè£œé ã
ãæ¹æ³ïŒããã©ãããã³ã32ã1713â1718
ïŒ1977ïŒãããã©ãããã³ã32ã1893ïŒ1977ïŒãã
ãã©ãããã³ãã¬ã¿ãŒãºã27ã1255ïŒ1986ïŒã
26ã407ïŒ1985ïŒã5875ïŒ1984ïŒãã¶ã»ãžã€ãŒã
ã«ã»ã¢ã¡ãªã«ã³ã»ã±ãã«ã«ã»ãœãµã€ãšãã€ãŒã
106ã3695ïŒ1984ïŒåç
§ïŒ
(2) åºçºååç©ãšããŠïŒ€åã¯ïŒ¬âé
ç³é
žãçšãã
ãããïŒå·¥çšã®æäœã«ããåã¯ïŒ¬âïŒïŒïŒâ
ãžãšãŒãâïŒïŒïŒâã€ãœããããªãã³ãžãªãã·
ãã¿ã³ãšãããããšãªããªååç©ãšãåå¿ãã
ãŠæ¬¡ãã§å æ°Žå解ãã(R)åã¯(S)âïŒâãããã
ã·âïŒâã·ã¯ããã³ããã³ã補é ããæ¹æ³ïŒã
ãã©ãããã³ã»ã¬ã¿ãŒãºã10ã759ã762ïŒ1976ïŒ
åç
§ïŒã
(3) åºçºç©è³ªãšããŠã埮çç©ã®ä»£è¬ç£ç©ã§ããã
ã©ã€ã³ãšããååç©ãããïŒå·¥çšãçµãŠïŒ(R)â
ã¢ã»ããã·âïŒâã·ã¯ããã³ããã³ã補é ãã
æ¹æ³ïŒããã©ãããã³ã¬ã¿ãŒãºãïŒ29ïŒã2553ã
2556ïŒ1978ïŒåç
§ïŒã
(4) ïŒïŒïŒïŒïŒâããªã¯ããããšããŒã«ããå¡©çŽ
ã§åå¿ããããŠãïŒïŒïŒïŒïŒâããªã¯ããâ
ïŒïŒïŒâãžããããã·ã·ã¯ããã³ãâïŒâãšã³
âïŒâã«ã«ãã³é
žãåŸãããããã«ã·ã³ã«ãŠå
åŠåå²ãã次ãã§ïŒå·¥çšã®æäœãçµãŠã(R)âïŒ
âïœâããã«ãžã¡ãã«ã·ããã·ã·ã¯ããã³ãâ
ïŒâãšãã³ã補é ããæ¹æ³ïŒããã©ãããã³ã»
ã¬ã¿ãŒãºã1539ã42ïŒ1979ïŒ(17)åç
§ïŒã
(5) ïŒâã·ã¯ããã³ãã³âïŒïŒïŒâãžãªã³ããã©
ã«ãªãããããŒã«ååç©ãšã¢ã«ã³ãŒã«ãšæ°ŽçŽ å
ãªããŠã ã¢ã«ãããŠã ãšããåŸãããååç©ã§
äžæéå
ããŠ(R)ãŸãã¯(S)ã®ïŒâããããã·âïŒ
âã·ã¯ããã³ããã³ãåŸãæ¹æ³ïŒéäŸããç¹é
æ56â123932åç
§ïŒã
(6) dlâïŒâããããã·âïŒâã·ã¯ããã³ããã³
ãšå
åŠåå²å€ãçµåãããçæç©ãïŒã€ã®ãžã¢
ã¹ãã¬ãªããŒãšããŠåé¢ããåŸåå²å€ãåå¿ã§
è±ä¿è·ããŠå
åŠæŽ»æ§äœãåŸããã®æ°Žé
žåºãå¿
èŠ
ã«å¿ããŠä¿è·ããŠè£œé ããæ¹æ³ïŒçŸœéããç¹é
æ57â159777ããã³éäŸããããã©ãããã³ã»
ã¬ã¿ãŒãºã23ã4057ïŒ1982ïŒåç
§ïŒã
(7) dlâïŒâããããã·âïŒâã·ã¯ããã³ããã³
ããªã«ãâãã¿ã«é
žã®ããŒããšã¹ãã«äœãšãã
ãããå
åŠæŽ»æ§ã¢ãã³ãšã®å¡©ãšããŠãåçµæ¶ã«
ããäžæ¹ã®ç°æ§äœãåé¢ããè±ä¿è·ããŠå
åŠæŽ»
æ§äœãåŸãæ°Žé
žåºãå¿
èŠã«å¿ããŠä¿è·ããŠè£œé
ããæ¹æ³ïŒæž¡èŸºããç¹éæ57â14560åç
§ïŒã
(8) âã°ã«ã³ãŒãºãåºçºåæãšããŠååŠå€æã«
ãã€ãŠåŸãæ¹æ³ïŒé³¥å±
ããã¶ã»ãžã€ãŒãã«ã»ãª
ãã»ãªã«ã¬ããã¯ã»ã±ãã¹ããªãŒã51ã254
ïŒ1986ïŒåç
§ïŒ
(9) ã·ã¯ããã³ãâïŒâãšã³âïŒâãªãŒã«ã®ïŒïŒ
ïŒâãšããã·ãã®äžæå¡©åºè§Šåªã«ããã¢ãªã«ã¢
ã«ã³ãŒã«ãžã®ç°æ§ååã³é
žåã«ããæ¹æ³ïŒæµ
èŠ
ããããã©ãããã³ã»ã¬ã¿ãŒãºã26ã5803
ïŒ1985ïŒåç
§ïŒ
çãç¥ãããŠããã
ãããã®æ¹æ³ã«ãããŠã¯ã(1)ã(2)ã®æ¹æ³ã¯åŸã
ããïŒâããããã·âïŒâã·ã¯ããã³ããã³é¡ã®
å
åŠåçãå
åã«æºè¶³ãåŸããã®ã§ã¯ãªãããŸã
ãã®ããŒã¿ã«åçãäœããã®ã§ããã(3)ã(4)ã®æ¹
æ³ã«ãã€ãŠã¯å
åŠåçã¯é«ããã(3)ã®æ¹æ³ã«ãã
ã°å
¥æãå°é£ãªãã©ã€ã³ãšããååç©ãåºçºç©è³ª
ãšããŠçšããŠããããŸã(4)ã®æ¹æ³ã«ãã€ãŠã¯è£œé
å·¥çšã«ãããŠå
åŠåå²ãè¡ããã®ã§ããããŸã
(3)ã(4)ã®ãããã®æ¹æ³ã®ããŒã¿ã«åçãå
åã«æº
足ãåŸããã®ã§ã¯ãªãã(5)ã®æ¹æ³ã¯åæã§ããïŒ
âã·ã¯ããã³ãã³âïŒïŒïŒâãžãªã³ãåºçºåæãš
ããŠé«äŸ¡ã§å
¥æãæ¯èŒçå°é£ã§ãããã®ãçšãã
ãšããé£ç¹ããããããã«(6)ã(7)ã®å
åŠåå²ã«ã
ãæ¹æ³ã§ã¯äžæ¹ã®å
åŠæŽ»æ§äœãšããŠå©çšåºæ¥ãã
ã®ã¯çè«çã«ãé«ã
50ïŒ
ã§ãããããŒã¿ã«åçã
å
åã§ã¯ãªãã(8)ã®ïŒ€âã°ã«ã³ãŒãºããã®èªå°ã¯
å
åŠåçã¯è¯ãããç®çç©ã«è³ããŸã§ã®å·¥çšæ°ã
é·ããšããæ¬ ç¹ãããã(9)ã®æ¹æ³ã§ã¯åºçºåæã®
å
¥æã容æã§ãªããå
åŠåçã90ïŒ
e.e.ãšæºè¶³ã§
ã¯ãªãã
ãŸããã·ã¯ããã³ã¿ã³âïŒïŒïŒâãžãªã³ã®åŸæ¥
ããã®è£œåã®æ¹æ³ãšããŠã¯ãβâã±ãã¢ãžãã³é
ž
ãšãã«ãšã¹ãã«ã®ãã€ãã¯ãã³ïŒDieckmannïŒ
çž®ååå¿ã«ããæ¹æ³ïŒã¢ãŒã«ã»ãªãã¿ãŒããã«ã
ãã«ã»ããã«ã»ã¢ã¯ã¿ã32ã1123ïŒ1949ïŒåã³ãž
ãšãŒã»ãšããã»ãããŒãºãããžã€ãŒãã«ã»ãªãã»
ã¢ã¡ãªã«ã³ã»ã±ãã«ã«ã»ãœãµã€ãšãã€ã75ã1731
ïŒ1953ïŒåç
§ïŒãããã¯ã¬ããªã³é
žãšãã«ãšã¹ã
ã«ã®ç°ååå¿ã«ããæ¹æ³ïŒãžãšãŒã»ã¹ã©ã¬ããã·
ã³ã»ã·ã¹ã282ïŒ1977ïŒåç
§ïŒãç¥ãããŠãããã
ãããªããããããã®æ¹æ³ã¯åçãæäœã®è€éã
ããèŠãŠå¿
ãããå·¥æ¥çç£äžæºè¶³ãã¹ãæ¹æ³ã§ã¯
ãªãããŸããã·ã¯ããã³ã¿ãžãšã³ãçšããŠïŒâã·
ã¯ããã³ãã³ãžãªãŒã«ãçµç±ããŠåŸãæ¹æ³ãç¥ã
ããŠããïŒãšã«ã»ãšãã»ãªãŒã³ãããžã€ãŒãã«ã»
ãªãã»ã¶ã»ã±ãã«ã«ã»ãœãµã€ãšãã€ãŒã4035
ïŒ1952ïŒïŒãžãŒã»ãšã ã»ã³ã©ã·ãŠãããªã«ã¬ãã
ã¯ã»ã·ã³ã»ã·ã¹ã42ã50ïŒ1962ïŒïŒãžãŒã»ãšããã»
ã©ã¹ã ãã»ã³ãããªã«ã¬ããã¯ã»ã·ã³ã»ã·ã¹ã
VolVã234ïŒ1973ïŒïŒãžã€ãŒãã«ã»ãªãã»ã¶ã»ãª
ã«ã¬ããã¯ã»ã±ãã¹ããªãŒã37ã2905ïŒ1972ïŒå
ã³ãããã®åŒçšæç®åç
§ïŒããããããããã®æ¹
æ³ãåçãå·¥çšã®è€éãã®ç¹ã«ãããŠæ¬ ç¹ãæã
ãŠããã
ãŸããæè¿ãã«ãã«ãã³ãçšããïŒïŒïŒâã·ã¯
ããã³ã¿ã³ãžãªã³ã®æå©ãªè£œæ³ãææ¡ãããïŒã·
ãŒã»ãªãã¯ããã±ãã·ãšã»ããªããã111ã2461
ïŒ1978ïŒåç
§ïŒããã®æ¹æ³ã¯ãããŸã§ã®è£œæ³ã«æ¯ã
ãŠãã®çç£æ§ã¯èããåäžããæ¹æ³ã§ããããã
ããå·¥çšã¯æ°æ®µéã§ãããæäœã®é¢ã§å¿
ãããæº
足ãã¹ããã®ã§ãªãã
ãŸããïŒïŒïŒâãšããã·ã·ã¯ããã³ã¿ãã³ãç°
æ§åããŠåŸãæ¹æ³ãææ¡ãããŠããïŒç¹éæ55â
069537ãã¶ã»ãžã€ãŒãã«ã»ã¢ã¡ãªã«ã³ã»ã±ãã«
ã«ã»ãœãµã€ãšãã€ãŒã102ã2095ïŒ1980ïŒåç
§ãã
ãã®æ¹æ³ã¯ç段éã§ããããåçã¯æºè¶³ãã¹ã
ãã®ã§ã¯ãªãã
ïŒçºæã®ç®çïŒ
ãã®ããã«åŸæ¥ã®ãå
åŠæŽ»æ§ãªïŒâããããã·
âïŒâã·ã¯ããã³ããã³ããã³ïŒïŒïŒâã·ã¯ãã
ã³ã¿ã³ãžãªã³ã®è£œé æ³ã¯ãå¿
ãããå·¥æ¥çã«åªã
ããã®ãšã¯èšããªããã®ã§ããã
ããã§æ¬çºæè
ãã¯ã容æã«å
¥æãåŸãååç©
ãçšããŠãå
åŠåçãé«ãããŸãããŒã¿ã«åçã
é«ããå·¥æ¥çã«æå©ãªå
åŠæŽ»æ§ïŒâããããã·â
ïŒâã·ã¯ããã³ããã³ããã³ïŒïŒïŒâã·ã¯ããã³
ã¿ã³ãžãªã³ã®è£œé æ³ãèŠåºãã¹ãéæç 究ããã
ããªãã¡ãåŸæ¥ããç¥ãããŠããã¢ãªã«ã³ãŒã«ã
äžæ觊åªã«ããïŒïŒïŒâæ°ŽçŽ ç§»ååå¿ã«ããäžæ
ã®ã«ã«ããã«ååç©ãäžãããšããç¥èŠïŒã¬ãŒ
ã¿ã»ããã¢ã»ã€ã¿ãªã¢ãŒãã106ã1131ïŒ1976ïŒã
ããŠã¢ãŒã»ã¢ã³ãã»ã¢ãã©ã€ãã»ã±ãã¹ããªãŒã
57ã1845ïŒ1985ïŒåç
§ïŒã«çç®ããïŒâãããã
ã·âïŒâã·ã¯ããã³ããã³ãåæã«äžæããžãŠã
觊åªãæ¥è§Šãããããšã«ãããé床è«çåå²ã«ã
ãå
åŠæŽ»æ§ãªïŒâããããã·âïŒâã·ã¯ããã³ã
ãã³ããã³ïŒïŒïŒâã·ã¯ããã³ã¿ã³ãžãªã³ãå¹ç
è¯ãåŸãããããšãèŠåºããæ¬çºæã«å°éããã
ã®ã§ããã
ïŒçºæã®æ§æïŒ
ããªãã¡æ¬çºæã¯äžèšåŒãã
ãåŒäžããããç·ã¯Î±ããã³Î²âçµåã®ä»»æã®æ¯
ãè¡šãããã
ã§è¡šããããïŒâããããã·âïŒâã·ã¯ããã³ã
ãã³ãå
åŠæŽ»æ§ããžãŠã é¯äœãšæ¥è§Šãããããšã
ç¹åŸŽãšããäžèšåŒãã
ãåŒäžãïŒå°ã¯å
åŠæŽ»æ§ãèªèµ·ãããäžæççŽ å
åãè¡šãããã
ã§è¡šããããå
åŠæŽ»æ§ïŒâããããã·âïŒâã·ã¯
ããã³ããã³åã³ïŒïŒïŒâã·ã¯ããã³ã¿ã³ãžãªã³
ã®è£œæ³ã§ããã
æ¬çºæã®è£œé æ³ã§ã¯ãåºçºåæãšããŠåèšåŒ
ããã§è¡šããããïŒâããããã·âïŒâã·ã¯ã
ãã³ããã³ãçšããããããç·ã¯æ°Žé
žåºã®çµåã
αããŸãã¯Î²çµåã®ä»»æã®æ¯ãè¡šããããã®æ¯ã
ïŒïŒïŒãããªãã¡dläœã¯åŸæ¥ç¥ãããæ¹æ³ã«ãã
容æã«åŸãããšãåºæ¥ãïŒéäŸããç¹éæ54â
154735ãç°äžããç¹éæ56â086128åç
§ïŒããŸã
åºçºåæããã¥ããã®å
åŠç°æ§äœãéå°ã«ãªã€ãŠ
ãããã®ãããªãã¡Î±ïŒÎ²æ¯ãïŒä»¥äžãŸãã¯ïŒä»¥
äžã®ãã®ããã®è£œæ³ã®åæãšããŠäŸããããšãåº
æ¥ãã
ãããïŒâããããã·âïŒâã·ã¯ããã³ããã³
ãå
åŠæŽ»æ§ãªããžãŠã é¯äœãšåŠçããããšã«ãã€
ãŠãé床è«çåå²ãè¡ãªããçæç©ãšããŠå
åŠæŽ»
æ§ïŒâããããã·âïŒâã·ã¯ããã³ããã³ãšïŒïŒ
ïŒâã·ã¯ããã³ã¿ã³ãžãªã³ãåæã«åŸããããã
ãã§çšããããå
åŠæŽ»æ§ããžãŠã é¯äœã¯äžèšåŒ
ãã
ïŒRhïŒbinapïŒLnïŒ

âŠâŠãã
ãåŒäžãbinapã¯å
åŠæŽ»æ§ïŒïŒ2â²âãã¹ïŒãžããš
ãã«ãã¹ãã€ãïŒâïŒïŒ1â²âããããã«ã§ããã
ã¯é
äœåãè¡šãããã¯ããŒã¯ãã¬ãŒããŸãã¯
ããã©ãã«ãªããã¬ãŒããè¡šãããïœã¯ïŒãŸãã¯
ïŒã®æŽæ°ãè¡šãããã
ã§è¡šãããããããªãã®ã§ãããã®é
äœåã¯ã·
ã¯ããªã¯ã¿ãžãšã³ããã«ãã«ããžãšã³ãã¡ã¿ããŒ
ã«ãã¢ã»ãã³çããããç¹ã«ã·ã¯ããªã¯ã¿ãžãš
ã³ãã¡ã¿ããŒã«ãè¯ãã
ãããé¯äœã¯å
¬ç¥ã®æç®ïŒäŸãã°æ¥æ¬å
¬éå
¬å ±
53â13605ãã¶ã»ãžã€ãŒãã«ã»ãªãã»ã¢ã¡ãªã«
ã³ã»ã±ãã«ã«ã»ãœãµã€ãšãã€ãŒã102ã7932
ïŒ1980ïŒåç
§ïŒã«èšèŒãããæ¹æ³ã«ãã容æã«èª¿
補ãããã
ããããŠèª¿è£œãããå
åŠæŽ»æ§ããžãŠã é¯äœã¯å
æãšæ¥è§Šãããããšã«ãããäžæ¹ã®å
åŠç°æ§äœã
åªå
ããŠç°æ§ååå¿ãèµ·ãããïŒïŒïŒâã·ã¯ãã
ã³ã¿ã³ãžãªã³ãšããŠçæããªãããå
åŠæŽ»æ§ã®èª
èµ·ãããïŒâããããã·âïŒâã·ã¯ããã³ããã³
ãçããçµæãšãªããåå¿ã§ã¯åªäœã䜿çšããã
ãšãåºæ¥ãäŸãã°ããã©ããããã©ã³ããšãŒã
ã«ããžãªãµã³çã®ãšãŒãã«é¡ãç¹ã«å¥œãŸããã¯ã
ãã©ããããã©ã³ããããããäŸãã°ãã«ãšã³ã
ãã·ã¬ã³ããã³ãŒã³çã®è³éŠæçåæ°ŽçŽ é¡ãç¹ã«
奜ãŸããã¯ãã«ãšã³ãããããããçšããããåª
äœã¯åæã«å¯ŸããŠïŒéšã100éšã奜ãŸããã¯10éš
ã50éšãçšããããã
åå¿ã¯éåžžã¯â20âã70âã奜ãŸããã¯âïŒâ
ã30âã§é²è¡ãããåå¿ã®é²è¡ã¯ãããã³â
nmrãèå±€ã¯ãããã°ã©ãã€ãŒçã®æ段ã«ããè¿œ
è·¡åºæ¥ããåå¿æéã¯ç®çã®çæç©ã®æ§ç¶ã«å¿ã
ãŠèšå®åºæ¥ãã
çæç©ã¯ãã¥ããéåžžã«æ°Žã«æº¶ããããã®ã§ã
åå¿æ··åç©ãçŽæ¥ãã©ãã·ãŠã«ã©ã ã¯ãããã°ã©
ãã€ãŒãªã©ã®æ段ã«ããåé¢ç²Ÿè£œããã®ãè¯ãã
ãŸããªã³é
žç·©è¡æ¶²ïŒPH7.4ïŒãå ããŠææ©æº¶åªã§
æœåºããããæ°Žå±€éšã¯å床æžå§æ¿çž®ããåŸãææ©
溶åªã§æœåºããŠçæç©ãããã«åŸããæœåºæº¶åªãš
ããŠã¯é
¢é
žãšãã«ãŸãã¯ã¡ãã«ã€ãœããã«ã±ãã³
ã奜ãŸããçšããããã
ãŸãçæç©ã®ã²ãšã€ã®ã·ã¯ããã³ã¿ã³âïŒïŒïŒ
âãžãªã³ã¯åªäœäžã§çµæ¶ããå Žåãããããéã«
ãã容æã«åé¢ããããšãåºæ¥ãã
ããããŠåèšåŒããã§ç€ºãããå
åŠæŽ»æ§ïŒâ
ããããã·âïŒâã·ã¯ããã³ããã³ããã³ïŒïŒïŒ
âã·ã¯ããã³ã¿ã³ãžãªã³ãåŸãããã
å
åŠæŽ»æ§ïŒâããããã·âïŒâã·ã¯ããã³ãã
ã³ã¯å¿
èŠã«å¿ããŠæŽã«ãã®æ°Žé
žåºãä¿è·ããããŠ
ãããã
ãããååç©ã®æ°Žé
žåºãä¿è·ããã«ã¯ãå
¬ç¥ã®
åå¿ãæ¡çšããããšãã§ããã
ããªãã¡ãä¿è·åºãäŸãã°ã¢ã»ãã«åºãããã
ãã€ã«åºãã¯ããã¢ã»ãã«åºããã³ãŸã€ã«åºãïœ
âããã¢ãã³ãŸã€ã«åºãïœâããããã³ãŸã€ã«
åºãã¢ãã·ã€è©Šè¬çã®ã¢ã·ã«åºã®å Žåã«ã¯ãé
žã
ãã²ã³åç©ãããã¯é
žç¡æ°Žç©ãšããªãžã³ãšãåå¿
ããããããšã«ãã容æã«ä¿è·åºãå°å
¥ããããš
ãã§ããããŸãä¿è·åºãããªã¡ãã«ã·ãªã«åºããž
ã¡ãã«âïœâããã«ã·ãªã«åºçã®ããªã¢ã«ãã«ã·
ãªã«åºã®å Žåã«ã¯ãããªã¢ã«ãã«ã·ãªã«ããã²ã³
åç©ãšã€ãããŸãŒã«ãšãããµã¡ãã«ãã¹ããªãã¯
ããªã¢ãããåå¿ããããããšã«ãã€ãŠä¿è·åºã
å°å
¥ããããšãã§ããããŸãä¿è·åºãïŒâããã©
ããããã©ãã«åºïŒïŒâããã©ããããã©ãã«
åºãαâãšããã·ãšãã«åºãαâãšããã·âαâ
ã¡ãã«ãšãã«åºçã®å Žåã¯å¯Ÿå¿ããããã«ãšãŒã
ã«ååç©ã§ãããžããããã©ã³ããžããããã©
ã³ããšãã«ããã«ãšãŒãã«ããšãã«ã€ãœãããã
ã«ãšãŒãã«ããã©ãã«ãšã³ã¹ã«ãã³é
žãªã©ã®é
žæ§
觊åªååšäžã«æ¥è§Šããããããšã«ããä¿è·åºãå°
å
¥ããããšãã§ããã
ãã®ä¿è·ãããæ°Žé
žåºãæããçæç©ã¯ãã®å
åŠçŽåºŠãããã«äžããããã«åçµæ¶çã®æ段ã§åŠ
çããŠãè¯ããç¹ã«ä¿è·åºãããã«ãžã¡ãã«ã·ãª
ã«åºã®å Žåã¯äœæž©ã§äŸãã°ãã³ã¿ã³ããããµã³ç
ã®é
žåæ°ŽçŽ é¡ãçšããŠåçµæ¶ãããå
åŠçŽåºŠãäž
ããããšãåºæ¥ãã
以äžã®åŠãããŠãçš®ã
ã®ããã¹ã¿ã°ã©ã³ãžã³é¡
ã®åæäžéäœãšãªãåŸãå
åŠæŽ»æ§ãªïŒâãããã
ã·âïŒâã·ã¯ããã³ããã³ãã容æã«å
¥æãåŸã
ïŒâããããã·âïŒâã·ã¯ããã³ããã³ããé«ã
å
åŠåçã§å¹çãã補é ããããšãåºæ¥ãããã
åæã«ïŒïŒïŒâã·ã¯ããã³ã¿ã³ãžãªã³ãåŸãããš
ãåºæ¥ãããã®è£œæ³ã¯åæãšããŠçšããïŒâãã
ããã·âïŒâã·ã¯ããã³ããã³ã®éªšæ Œæ§é ãã»ãŒ
å®éçã«å©çšåºæ¥ãç¹ã«ãããæ¯èŒçé«ãå
åŠæŽ»
æ§ãç°¡åã«ãããæž©åãªæ¡ä»¶ã§èªèµ·åºæ¥ãç¹ã§ã
ããåŸæ¥ã®æ¹æ³ã«æ¯ã¹ãŠéåžžã«å·¥çšæ°ãçããã
ç®çã®å
åŠæŽ»æ§äœãåŸãããšãåºæ¥ããæ°èŠã§æ
å©ãªæ¹æ³ãšèšããã
ïŒå®æœäŸïŒ
以äžãæ¬çºæãå®æœäŸã«ããæŽã«è©³çŽ°ã«èª¬æã
ãã
å®æœäŸ ïŒ
ããããã也ç¥ãã¢ã«ãŽã³çœ®æããïŒmm管
NMR管ã«çŽïŒmgã®Rhã(R)âbinapã
ïŒCH3OHïŒ2ã+ClO4 -ãèšãåãããããªãŠã âã«
ãªãŠã ããèžçããããªãŠã ãããŒäžã«ä¿åãã
éæ°ŽçŽ åããã©ããããã©ã³ïŒTHFâd3ïŒã0.5
mlèžçã«ãã€ãŠå°å
¥ãããè±æ°ã也ç¥æžã¿ã®
ïŒÂ±ïŒâïŒâããããã·âïŒâã·ã¯ããã³ããã³
ïŒ25ÎŒïŒããã€ã¯ãã·ãªã³ãžã§ãã¢ã«ãŽã³æ°æµ
äžãâ78âã§å
ã«çšæããTHFâd3ã®è§Šåªæº¶æ¶²
ïŒäžéšäžæº¶ïŒã«å°å
¥ãããïŒåã®è±æ°æäœåŸïŒâ
ã«ææž©ãã13æ¥éæŸçœ®ããããã®éã«å®å
šã«æº¶æ¶²
ãšãªããé»æ©ã
è²ããæ¿ãç·è²ã®æº¶æ¶²ãžãšå€åã
ãã
åå¿æ··å液ãçŽæ¥ããã©ãã·ãŠã«ã©ã ã¯ããã
ã«äŸãïŒã·ãªã«ã²ã«ïŒïœããšãŒãã«âãããµã³
ïŒïŒ1.5âãšãŒãã«âãžã¯ããã¡ã¿ã³âã¡ã¿ããŒ
ã«ïŒïŒïŒïŒè§Šåªãç®çç©ã®8.5mgã®ïŒâãããã
ã·âïŒâã·ã¯ããã³ããã³(A)ããã³17.9mgã®ïŒïŒ
ïŒâã·ã¯ããã³ã¿ã³ãžãªã³(B)ãåé¢ãããåé¢ã
ãïŒâããããã·âïŒâã·ã¯ããã³ããã³ã¯ãã
ã¡ã«ã¡ãã¬ã³ã¯ããªãïŒ0.5mlã«æº¶ãããã¢ãã·
ã€ãŒè©Šè¬ïŒïŒïŒïŒâMTPAClïŒïŒ20ÎŒïŒãšããªãž
ã³ïŒ50ÎŒïŒãå ãã宀枩ïŒãïŒæéæŸçœ®ããã
åå¿æ··å液ãé
žæ§æ¡ä»¶äžããšãŒãã«ïŒå
šéçŽ15
mlïŒã§æœåºããææ©å±€ã飜åé£å¡©æ°Žã§æŽæµåŸãç¡
æ°Žç¡«é
žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠé»è²æ²¹ç¶ç©
質ãåŸãããã®æ··åç©ããã©ãã·ãŠã¯ãããïŒã·
ãªã«ã²ã«ïŒïœããšãŒãã«âãããµã³ïŒïŒïŒâïŒïŒ
ïŒïŒã§åé¢ã24mgã®ïŒïŒïŒMTPACãšã¹ãã«äœã
åŸããHPLCåæã«ãã87ïŒ
eeãšæ±ºå®ããã
å®æœäŸ ïŒãïŒ
å®æœäŸïŒãšåæ§ãªåååŠçåå²ãå®æœããäžè¡š
ã«ç€ºããããã«ã觊åªã溶åªã枩床ãæéçã®
çš®ã
ã®æ¡ä»¶äžã§ã®çµæãåŸãã
ãè¡šã
ãè¡šã
åèäŸ ïŒ
ïŒ(R)âïœâããã«ãžã¡ãã«ã·ããã·âïŒâã·ã¯
ããã³ãã³âïŒâãªã³ã®åæ
ïŒ(R)âããããã·âïŒâã·ã¯ããã³ãã³âïŒâ
ãªã³1.84mgïŒ1.88ïœmolïŒããããµã¡ãã«ãã¹ã
ãªãã¯ããªã¢ããïŒNMPAïŒïŒmlã«ãšãããïŒ
âã«ãŠïœâããã«ãžã¡ãã«ã·ãªã«ã¯ãã©ã€ã369
mgïŒ2.45ïœmolïŒãå ãããã®ãŸãŸçµå€æ¹æã
ããåå¿åŸãšãŒãã«ãå ããåŸæ°ŽæŽãè¡ããšæ²¹ç¶
ç©320mgãåŸãããããããã«ã©ã ã¯ãããã°ã©
ãã€ãŒã«ä»ããïœâãããµã³âé
¢é
žãšãã«ïŒïŒïŒ
ïŒïŒã«ãã粟補ããããšã«ããïŒ(R)âïœâããã«
ãžã¡ãã«ã·ããã·âïŒâã·ã¯ããã³ãã³âïŒâãª
ã³294mgïŒ74ïŒ
ïŒãåŸãããã
ãα23 DïŒïŒ55.7° ïŒ0.42 MeOH
åèäŸ ïŒ
åçµæ¶âïŒ
åŸãããå
åŠçŽåºŠ87ïŒ
eeã®ïŒ(R)âïœâããã«â
ãžã¡ãã«ã·ããã·âïŒâã·ã¯ããã³ããã³2.360
ïœïŒå®€æž©ã§çµæ¶ïŒïŒïŒ²äœïŒ2.207ïœãäœïŒ0.153
ïœïŒã200mlãã¹ãã©ã¹ã³ã«æ¡ããã³ã¿ã³110mlã«
溶解ããããããN2äžã§ã€ãœãããã«ã¢ã«ã³ãŒ
ã«ã®å·åŽãã¹ã«ã€ãå·åŽãã¹ã«ãã©ã€ã¢ã€ã¹çã
å°ãã¥ã€å
¥ãåŸã
ã«å·åŽãããçŽâ45âã§çœè²é
ç¶ã®çµæ¶ãçæããã枩床ãçŽâ50âã«ä¿ã¡ïŒæ
éé眮åŸãâ50âã«å·åŽãã3Gâã°ã©ã¹ãã€ã«ã¿
ãŒã«ç§»ãç¬æã«äœæž©æžå§éããã
åé¢ããçµæ¶éšãæžå§ä¹Ÿç¥ããŠ0.755ïœïŒ32ïŒ
ïŒ
ã®çµæ¶âãåŸããåæ¯æ¶²ãæžå§æ¿çž®ã»æžå§ä¹Ÿç¥
ããŠ1.605ïœïŒ68ïŒ
ïŒã®æ¯æ¶²âïŒå®€æž©ã§çµæ¶ïŒ
ãåŸãã
ãããã®m.p.å
åŠçŽåºŠãåéã¯äžè¡šã®éãã§ã
ãã
ãè¡šã
åçµæ¶âïŒ
åçµæ¶âïŒã§ã®æ¯æ¶²â1.605ïœããã³ã¿ã³70
mlã«æº¶è§£ããåçµæ¶âïŒãšåæ§ã«â50âã§ã®äœæž©
åçµæ¶æäœãè¡ã1.042ïœïŒåé44ïŒ
ïŒã®çµæ¶â
ãš0.563ïœïŒ24ïŒ
ïŒã®æ¯æ¶²âïŒãåŸãã
ãããã®å
åŠçŽåºŠãåéã¯äžè¡šã®éãã§ããã
ãè¡šã DETAILED DESCRIPTION OF THE INVENTION <Industrial Field of Application> The present invention relates to a method for producing optically active 4-hydroxy-2-cyclopentenone and related compounds.
More specifically, the present invention involves contacting 4-hydroxy-2-cyclopentenone with an optically active rhodium complex to selectively isomerize one optical isomer to form 1,3-cyclopentanedione;
At the same time, optical activity of R or S coordination was induced 4
-Regarding a new method for producing hydroxy-2-cyclopentenone. According to this production method, optically active 4-hydroxy-2-cyclopentenones, which are intermediates for the production of various pharmaceuticals such as prostaglandins with various pharmacological effects and maytansine with anticancer effects, can be produced in high yield. Furthermore, this production method is extremely significant from the viewpoint of stereochemistry. <Prior art> Conventionally, optically active 4-hydroxy-2-cyclopentenones such as (R)-4-hydroxy-2-cyclopentenone and (S)-4-hydroxy-2-cyclopentenone have been produced. For example, the following manufacturing method is known. That is, (1) diacetoxycyclopent-1-ene obtained from cyclopentadiene is hydrolyzed with an enzyme to obtain 3(R)-acetoxy-5(R)-hydroxycyclopent-1-ene; is oxidized with manganese dioxide to obtain 4(R)-acetoxycyclopent-2-en-1-one, which is optionally deprotected with a hydrolase (tetrahedron, 32 , 1713â1718
(1977), Tetrahedron, 32 , 1893 (1977), Tetrahedron, Letters, 27 , 1255 (1986),
26, 407 (1985), 5875 (1984), The Journal American Chemical Society,
106, 3695 (1984)) (2) Using D or L-tartaric acid as a starting compound,
D or L-1,4-
A method for producing (R) or (S)-4-hydroxy-2-cyclopentenone by reacting diiodo-2,3-isopropylidene dioxybutane with a lithio compound and then hydrolyzing it (tetra Hedron Letters, 10 , 759â762 (1976)
(3) As a starting material, 4(R)-
Method for producing acetoxy-2-cyclopentenone (Tetrahedron Letters, ( 29 ), 2553~
2556 (1978)), (4) 2,4,6-trichlorophenol is reacted with chlorine to form 3,5,5-trichloro-
1,4-dihydroxycyclopent-2-ene-1-carboxylic acid was obtained, which was optically resolved with brucine, and then subjected to four steps to obtain (R)-4.
-t-butyldimethylsiloxycyclopent-
Method for producing 2-enone (tetrahedron)
Letters, 1539-42 (1979) (17)), (5) Asymmetric reduction of 1-cyclopentene-3,5-dione with a compound obtained from a chiral binaphthol compound, an alcohol, and lithium aluminum hydride ( 4-hydroxy-2 of R) or (S)
- A method for obtaining cyclopentenone (see Noyori et al., JP-A-123932), (6) combining dl-4-hydroxy-2-cyclopentenone with an optical resolving agent to separate the product into two diastereomers. After separation, the resolving agent is deprotected by reaction to obtain an optically active compound, and the hydroxyl group is protected as necessary to produce the product (Hari et al., JP-A-159777 and Noyori et al., tetrahedron.
Letters, 23, 4057 (1982)), (7) dl-4-hydroxy-2-cyclopentenone as a half ester of ortho-phthalic acid,
This is converted into a salt with an optically active amine, one isomer is separated by recrystallization, the optically active form is obtained by deprotection, and the hydroxyl group is protected as necessary. 57-14560), (8) A method for obtaining D-glucose by chemical conversion using it as a starting material (Torii et al., The Journal of Organ Chemistry, 51, 254
(1986)) (9) 3 of cyclopent-3-en-1-ol,
Isomerization and oxidation of 4-epoxide to allyl alcohol using an asymmetric base catalyst (Asami et al., Tetrahedron Letters, 26, 5803)
(1985)) are known. In these methods, the optical yield of the 4-hydroxy-2-cyclopentenones obtained by methods (1) and (2) is not fully satisfactory, and the total yield is also low. Although methods (3) and (4) have high optical yields, method (3) uses a compound called terrain, which is difficult to obtain, as a starting material; In the method described above, optical resolution is performed during the manufacturing process, and
The total yield of either method (3) or (4) is not fully satisfactory. Method (5) is raw material 1
The disadvantage is that -cyclopentene-3,5-dione is used as a starting material which is expensive and relatively difficult to obtain. Furthermore, in the optical resolution methods (6) and (7), only 50% of one optically active substance can be used theoretically, and the total yield is not sufficient. Although the induction of (8) from D-glucose has a good optical yield, it has the disadvantage of requiring a long number of steps to reach the target product. In method (9), the starting materials are not easily available and the optical yield is unsatisfactory at 90% ee. In addition, as a conventional method for producing cyclopentane-1,3-dione, Dieckmann (β-ketoadipate ethyl ester)
Condensation reaction method (Earl Richter, Helvetica Chimica Acta, 32 , 1123 (1949) and J.E.T. Brose et al., Journal of
American Chemical Society, 75 , 1731
(1953)) or the cyclization reaction of levulinic acid ethyl ester (see J. Slaga et al., Synthesis, 282 (1977)). However, these methods are not necessarily satisfactory for industrial production in terms of yield and operational complexity. In addition, a method of obtaining 4-cyclopentenediol using cyclopentadiene is known (L.N.O.N et al., Journal.
of the Chemical Society, 4035
(1952): G.M. Colaciu et al., Organic Synthesis, 42 , 50 (1962): G.H.
Rasmutsen et al., Organic Synthesis;
VolV, 234 (1973): Journal of the Organ Chemistry, 37 , 2905 (1972) and references cited therein). However, these methods also have drawbacks in terms of yield and process complexity. In addition, an advantageous process for the preparation of 1,3-cyclopentanedione using norbornene has recently been proposed (see Rick et al., Chemisier Berichte, 111 , 2461).
(1978)). This method has significantly improved productivity compared to conventional manufacturing methods. However, the process involves several steps and is not necessarily satisfactory in terms of operation. Additionally, a method has been proposed to obtain 2,3-epoxycyclopentanone by isomerizing it (Japanese Patent Application Laid-open No. 1983-1979-
069537, The Journal American Chemical Society, 102 , 2095 (1980)]. Although this method is short-step, the yield is unsatisfactory. <Object of the invention> As described above, conventional methods for producing optically active 4-hydroxy-2-cyclopentenone and 1,3-cyclopentanedione cannot necessarily be said to be industrially superior. . Therefore, the present inventors have developed an industrially advantageous optically active 4-hydroxy-4-hydroxy compound that has a high optical yield and a high total yield, using easily available compounds.
We conducted extensive research to find a method for producing 2-cyclopentenone and 1,3-cyclopentanedione.
That is, the knowledge that the conventionally known allylcol gives an asymmetric carbonyl compound through a 1,3-hydrogen transfer reaction using an asymmetric catalyst (Gazeta Chimia Italiana, 106 , 1131 (1976),
pure and applied chemistry,
57, 1845 (1985)), optically active 4-hydroxy-2-cyclopene was produced by kinetic resolution by contacting 4-hydroxy-2-cyclopentenone with an asymmetric rhodium catalyst. The present invention was achieved by discovering that tenone and 1,3-cyclopentanedione can be obtained efficiently. <Structure of the invention> That is, the present invention has the following formula [] [In the formula, the ~ ~ ~ line represents an arbitrary ratio of α and β-bonds. ] The following formula [] is characterized by contacting 4-hydroxy-2-cyclopentenone represented by with an optically active rhodium complex. [In the formula, * represents an asymmetric carbon atom in which optical activity is induced. ] This is a method for producing optically active 4-hydroxy-2-cyclopentenone and 1,3-cyclopentanedione represented by the following. In the production method of the present invention, 4-hydroxy-2-cyclopentenone represented by the above formula [] is used as a starting material. ~ ~ ~ The line represents an arbitrary ratio of hydroxyl group bonds to α or β bonds, and the ratio is 1/1, that is, the dl form can be easily obtained by a conventionally known method (Noyori et al., JP-A No. Showa 54-
154735, Tanaka et al., JP-A-56-086128). Further, starting materials containing an excess of one of the optical isomers, that is, those having an α/β ratio of 1 or more or 1 or less, can also be used as raw materials for this production method. By treating such 4-hydroxy-2-cyclopentenone with an optically active rhodium complex, kinetic resolution is performed, and the products are optically active 4-hydroxy-2-cyclopentenone and 1,
3-Cyclopentanedione is obtained at the same time. The optically active rhodium complex used here has the following formula [] <Rh(binap)Ln> - binaphthyl;
L represents a ligand, X represents perchlorate or tetrafluoroborate, and n represents an integer of 1 or 2. ] The ligand for L includes cyclooctadiene, norbornadiene, methanol, acetone, etc., and cyclooctadiene and methanol are particularly preferred. Such complexes are described in known literature (e.g. Japanese Publication No.
53â13605, The Journal of American Chemical Society, 102 , 7932
(1980)). When the optically active rhodium complex prepared in this manner is brought into contact with the raw material, one of the optical isomers undergoes an isomerization reaction preferentially, producing 1,3-cyclopentanedione while 4 having induced optical activity. -hydroxy-2-cyclopentenone results. A medium can be used in the reaction, for example ethers such as tetrahydrofuran, ether, diosane, particularly preferably tetrahydrofuran, for example toluene,
Aromatic hydrocarbons such as xylene and benzene, particularly preferably toluene. The medium used is used in an amount of 1 part to 100 parts, preferably 10 parts to 50 parts, based on the raw material. The reaction is usually carried out at -20°C to 70°C, preferably -5°C.
Proceeds at ~30°C. The reaction progresses with proton-
It can be traced by means such as nmr or thin layer chromatography, and the reaction time can be set depending on the properties of the desired product. All products are highly soluble in water, so
It is preferable to directly separate and purify the reaction mixture by means such as flash column chromatography.
It is also extracted with an organic solvent by adding phosphate buffer (PH7.4). The aqueous layer is concentrated again under reduced pressure and then extracted with an organic solvent to further obtain a product. Ethyl acetate or methyl isobutyl ketone is preferably used as the extraction solvent. Also, one of the products, cyclopentane-1,3
-Diones may crystallize in the medium and can be easily separated by filtration. Thus, the optically active 4- represented by the above formula []
Hydroxy-2-cyclopentenone and 1,3
- Cyclopentanedione is obtained. Optically active 4-hydroxy-2-cyclopentenone may further have its hydroxyl group protected as required. In order to protect the hydroxyl group of such a compound, a known reaction can be employed. That is, the protecting group is, for example, an acetyl group, a propanoyl group, a chloroacetyl group, a benzoyl group, a p
In the case of an acyl group such as a -bromobenzoyl group, p-nitrobenzoyl group, or Motsuya's reagent, a protecting group can be easily introduced by reacting an acid halide or acid anhydride with pyridine. When the protecting group is a trialkylsilyl group such as a trimethylsilyl group or a dimethyl-t-butylsilyl group, the protecting group is introduced by reacting a trialkylsilyl halide, imidazole, and hexamethylphosphoric triamide. be able to. In addition, the protecting group is 2-tetrahydropyranyl group; 2-tetrahydrofuranyl group, α-ethoxyethyl group, α-ethoxy-α-
In the case of a methyl ethyl group, etc., a protective group can be introduced by contacting the corresponding vinyl ether compound dihydropyran, dihydrofuran, ethyl vinyl ether, ethyl isopropenyl ether in the presence of an acidic catalyst such as para-toluenesulfonic acid. . This product having a protected hydroxyl group may be treated by means such as recrystallization to further increase its optical purity. In particular, when the protecting group is a butyldimethylsilyl group, it can be recrystallized at low temperature using hydrogen oxides such as pentane or hexane to increase the optical purity. As described above, optically active 4-hydroxy-2-cyclopentenone, which can be used as a synthetic intermediate for various prostaglandins, has an optical yield higher than that of easily available 4-hydroxy-2-cyclopentenone. 1,3-cyclopentanedione can be obtained at the same time. This production method is able to utilize the skeletal structure of 4-hydroxy-2-cyclopentenone used as a raw material almost quantitatively, and can induce relatively high optical activity easily and under mild conditions. The number of steps is very short compared to the method of
It can be said that this is a new and advantageous method that can obtain the desired optically active substance. <Example> Hereinafter, the present invention will be explained in more detail with reference to Examples. Example 1 5 mm tube that was previously dried and replaced with argon
Approximately 2 mg of Rh [(R)-binap] in the NMR tube
(CH 3 OH) 2 ] + ClO 4 - was weighed out, and 0.5% of deuterated tetrahydrofuran (THF-d 3 ), which had been distilled from sodium-potassium and stored in a sodium mitten, was added.
Introduced by ml distillation. Degassed and dried (±)-4-hydroxy-2-cyclopentenone (25ÎŒ) was added to the previously prepared THF- d3 catalyst solution (some insoluble ). 0â after two degassing operations
The temperature was raised to 1 and left for 13 days. During this time, it completely becomes a solution, changing from a yellow-orange color to a dark green solution. The reaction mixture was directly subjected to flash column chromatography (6 g of silica gel, ether-hexane 8:1.5 â ether â dichloromethane-methanol 9:1), and the catalyst and 8.5 mg of the target product 4-hydroxy-2-cyclopentenone ( A) and 17.9 mg of 1,
3-Cyclopentanedione (B) was separated. The separated 4-hydroxy-2-cyclopentenone is immediately dissolved in methylene chloride (0.5 ml), Motscher's reagent ((+)-MTPACl) (20 Ό) and pyridine (50 Ό) are added, and the mixture is left at room temperature for 1 to 5 hours. The reaction mixture was mixed with ether (total amount approx. 15%) under acidic conditions.
ml), and the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain a yellow oil. This mixture was subjected to flash chromatography (6 g of silica gel, ether-hexane 1:5 â 1:
Separation was performed in step 3) to obtain 24 mg of (+) MTPAC ester. Determined to be 87% ee by HPLC analysis. Examples 2-9 Kinetic resolution similar to Example 1 was carried out, and results were obtained under various conditions such as catalyst, solvent, temperature, time, etc., as shown in the table below. [Table] [Table] Reference Example 1 Synthesis of 4(R)-t-butyldimethylsiloxy-2-cyclopenten-1-one 4(R)-hydroxy-2-cyclopenten-1-
Dissolve 1.84 mg (1.88 mmol) of
t-Butyldimethylsilyl chloride at â369
mg (2.45 mmol) and stirred overnight. After the reaction, add ether and wash with water to obtain 320 mg of an oily substance. This was subjected to column chromatography and n-hexane-ethyl acetate (2:
Purification according to 1) yields 294 mg (74%) of 4(R)-t-butyldimethylsiloxy-2-cyclopenten-1-one. [α 23 D : +55.7° C: 0.42 MeOH Reference Example 2 Recrystallization-1 Obtained 4(R)-t-butyl- with optical purity of 87% ee
Dimethylsiloxy-2-cyclopentenone 2.360
g (crystal at room temperature) (R form = 2.207 g, S form = 0.153
Take g) in a 200ml eggplant flask and dissolve in 110ml of pentane. This is placed in a cooling bath of isopropyl alcohol under N2 , and pieces of dry ice are added little by little into the cooling bath to cool it down gradually. White needle-like crystals form at approximately -45°C. The temperature was kept at about -50°C and the mixture was allowed to stand for 1 hour, then transferred to a 3G glass filter cooled to -50°C and instantly filtered under low temperature under reduced pressure. Dry the separated crystal part under reduced pressure to give 0.755g (32%)
Crystals of were obtained. In addition, the mother liquor was concentrated under reduced pressure and dried under reduced pressure to obtain 1.605 g (68%) of the mother liquor (crystallized at room temperature).
I got it. The optical purity and yield of these mps are shown in the table below. [Table] Recrystallization-2 1.605g of mother liquor in Recrystallization-1 was mixed with 70g of pentane.
ml, and perform low temperature recrystallization at -50â in the same manner as in Recrystallization-1 to obtain 1.042g (yield 44%) of crystals.
and 0.563 g (24%) of mother liquor-2 was obtained. Their optical purity and yield are shown in the table below. ãtableã
Claims (1)
ãè¡šãããã ã§è¡šããããïŒâããããã·âïŒâã·ã¯ããã³ã
ãã³ãå åŠæŽ»æ§ããžãŠã é¯äœãšæ¥è§Šãããããšã
ç¹åŸŽãšããäžèšåŒãã ãåŒäžãïŒå°ã¯å åŠæŽ»æ§ãèªèµ·ãããäžæççŽ å
åãè¡šãããã ã§è¡šããããå åŠæŽ»æ§ïŒâããããã·âïŒâã·ã¯
ããã³ããã³åã³ïŒïŒïŒâã·ã¯ããã³ã¿ã³ãžãªã³
ã®è£œæ³ã ïŒ å åŠæŽ»æ§ããžãŠã é¯äœãäžèšåŒãã ïŒRhïŒbinapïŒLnïŒ ïŒž âŠâŠãã ãåŒäžãbinapã¯å åŠæŽ»æ§ïŒïŒ2â²âãã¹ïŒãžããš
ãã«ãã¹ãã€ãïŒâïŒïŒ1â²âããããã«ã§ããã
ã¯é äœåãè¡šãããã¯ããŒã¯ãã¬ãŒããŸãã¯
ããã©ãã«ãªããã¬ãŒããè¡šãããïœã¯ïŒãŸãã¯
ïŒã®æŽæ°ãè¡šãããã ã§è¡šããããé¯äœã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®å åŠæŽ»æ§ïŒâããããã·âïŒâã·ã¯ããã³ã
ãã³åã³ïŒïŒïŒâã·ã¯ããã³ã¿ã³ãžãªã³ã®è£œæ³ã ïŒ é äœåãã¡ã¿ããŒã«ãŸãã·ã¯ããªã¯ã¿ãžãšã³
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å åŠæŽ»æ§ïŒâ
ããããã·âïŒâã·ã¯ããã³ããã³åã³ïŒïŒïŒâ
ã·ã¯ããã³ã¿ã³ãžãªã³ã®è£œæ³ã[Claims] 1. The following formula [] [In the formula, the ~ ~ ~ line represents an arbitrary ratio of α and β-bonds. ] The following formula [] is characterized by contacting 4-hydroxy-2-cyclopentenone represented by with an optically active rhodium complex. [In the formula, * represents an asymmetric carbon atom in which optical activity is induced. ] A method for producing optically active 4-hydroxy-2-cyclopentenone and 1,3-cyclopentanedione. 2 The optically active rhodium complex has the following formula [] <Rh(binap)Ln> can be,
L represents a ligand, X represents perchlorate or tetrafluoroborate, and n represents an integer of 1 or 2. ] A method for producing optically active 4-hydroxy-2-cyclopentenone and 1,3-cyclopentanedione according to claim 1, which are complexes represented by the following. 3. Optically active 4- according to claim 2, wherein the ligand is methanol or cyclooctadiene.
Hydroxy-2-cyclopentenone and 1,3-
Production method of cyclopentanedione.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61132777A JPS62289542A (en) | 1986-06-10 | 1986-06-10 | Production of optically active 4-hydroxy-2-cyclopentenone or such and related compound thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61132777A JPS62289542A (en) | 1986-06-10 | 1986-06-10 | Production of optically active 4-hydroxy-2-cyclopentenone or such and related compound thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62289542A JPS62289542A (en) | 1987-12-16 |
JPH0535137B2 true JPH0535137B2 (en) | 1993-05-25 |
Family
ID=15089306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61132777A Granted JPS62289542A (en) | 1986-06-10 | 1986-06-10 | Production of optically active 4-hydroxy-2-cyclopentenone or such and related compound thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62289542A (en) |
-
1986
- 1986-06-10 JP JP61132777A patent/JPS62289542A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS62289542A (en) | 1987-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60123579T2 (en) | SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE | |
JP2019503400A (en) | Process for producing 3-((2S, 5S) -4-methylene-5- (3-oxopropyl) tetrahydrofuran-2-yl) propanol derivative and intermediate therefor | |
Yamaguchi et al. | Regioselective Preparation of Allylgermanes. | |
JP3138834B2 (en) | Method for producing fucopyranose analog and intermediate compound thereof | |
JPS6344743B2 (en) | ||
JPH0535137B2 (en) | ||
Piacenza | Nucleophilic substitution with inversion of alcohol configuration with the reagent complex triphenylphosphine-diethyl azodicarboxylate-carboxylic acid. A convenient preparation of epicholesterol | |
JPH023793B2 (en) | ||
JP2782756B2 (en) | Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same | |
JPH062707B2 (en) | Process for producing optically active 4-hydroxy-2-cyclopentenones | |
JPS5944336A (en) | Novel preparation of 2-allylcyclopentanones | |
JP5259045B2 (en) | Benzoprostacyclin intermediates and methods for their production | |
JP3712077B2 (en) | Hydroindan-4-ol derivative and method for producing the same | |
JPS6234025B2 (en) | ||
JPS6042775B2 (en) | 1,7-octadien-3-one and its manufacturing method | |
KR100543172B1 (en) | A Process for Preparing Terrein Compounds | |
JP3632135B2 (en) | Isocarbacycline derivative and method for producing the same | |
JP2737214B2 (en) | Method for producing 4-hydroxy-2-cyclopentenone derivative | |
JPS6236012B2 (en) | ||
JPH0578541B2 (en) | ||
JP2652248B2 (en) | Process for producing alkoxynitrile compounds | |
KR930006954B1 (en) | Method for producing 5-hydroxypentyl phosphate | |
JP2002212149A (en) | METHOD FOR PRODUCING TETRAALKYLAMMONIUM FLUORIDE AND METHOD FOR PRODUCING beta-HYDROXYKETONE BY USING THE SAME | |
JPH0733390B2 (en) | Method for isolating optically active 4-substituted-2-cyclopentenones | |
JPH03109383A (en) | Production of 2,3-dideoxyribose derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |